Sun Pharma hits 52-week high on USFDA approval, good Q1 results
newsdepo.com
Sun Pharm hit a 52-week high of Rs 618, up 3%, extending its Tuesday's 7% rally on the BSE.Sun Pharma hits 52-week high on USFDA approval, good Q1 results
Sun Pharm hit a 52-week high of Rs 618, up 3%, extending its Tuesday's 7% rally on the BSE. Read more